Cancer Biotherapy and Radiopharmaceuticals
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
- PublisherMARY ANN LIEBERT, INC
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1996
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Cancer Biotherapy and Radiopharmaceuticals been publishing? 
The Cancer Biotherapy and Radiopharmaceuticals has been publishing since 1996 till date.
How frequently is the Cancer Biotherapy and Radiopharmaceuticals published?
Cancer Biotherapy and Radiopharmaceuticals is published Monthly.
What is the H-index. SNIP score, Citescore and SJR of Cancer Biotherapy and Radiopharmaceuticals?
Cancer Biotherapy and Radiopharmaceuticals has a H-index score of 66, Citescore of 5.2, SNIP score of 0.71, & SJR of Q2
Who is the publisher of Cancer Biotherapy and Radiopharmaceuticals?
The publisher of Cancer Biotherapy and Radiopharmaceuticals is MARY ANN LIEBERT, INC.
How can I view the journal metrics of Cancer Biotherapy and Radiopharmaceuticals on editage?
For the Cancer Biotherapy and Radiopharmaceuticals metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Cancer Biotherapy and Radiopharmaceuticals?
The eISSN number is 1557-8852 and pISSN number is 1084-9785 for Cancer Biotherapy and Radiopharmaceuticals.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Lung cancer, Assay, Breast cancer, Overall survival, Western blot, Hepatocellular carcinoma, Doxorubicin, Radioguided Surgery, Radionuclide, Gene expression, Cell cycle, Hemoglobin, Clinical significance, Neuroendocrine tumors, Albumin, Colorectal cancer, Head and neck, Osteosarcoma, Immunohistochemistry, Progression-free survival.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.